Ingalls & Snyder LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.46M Sell
3,284
-40
-1% -$17.8K 0.05% 189
2025
Q1
$1.61M Buy
3,324
+334
+11% +$162K 0.05% 168
2024
Q4
$1.2M Buy
2,990
+2,000
+202% +$805K 0.05% 199
2024
Q3
$460K Buy
990
+63
+7% +$29.3K 0.02% 299
2024
Q2
$435K Sell
927
-106
-10% -$49.7K 0.02% 292
2024
Q1
$432K Hold
1,033
0.02% 299
2023
Q4
$420K Buy
1,033
+29
+3% +$11.8K 0.02% 294
2023
Q3
$349K Hold
1,004
0.02% 308
2023
Q2
$353K Hold
1,004
0.02% 315
2023
Q1
$316K Hold
1,004
0.02% 324
2022
Q4
$290K Hold
1,004
0.02% 335
2022
Q3
$291K Hold
1,004
0.02% 325
2022
Q2
$283K Sell
1,004
-7
-0.7% -$1.97K 0.01% 336
2022
Q1
$264K Buy
1,011
+4
+0.4% +$1.05K 0.01% 374
2021
Q4
$221K Buy
+1,007
New +$221K 0.01% 406
2021
Q3
Sell
-1,007
Closed -$203K 450
2021
Q2
$203K Sell
1,007
-193
-16% -$38.9K 0.01% 416
2021
Q1
$258K Hold
1,200
0.01% 368
2020
Q4
$284K Hold
1,200
0.01% 342
2020
Q3
$327K Hold
1,200
0.02% 278
2020
Q2
$348K Sell
1,200
-2,450
-67% -$711K 0.02% 295
2020
Q1
$869K Buy
3,650
+2,450
+204% +$583K 0.06% 208
2019
Q4
$263K Hold
1,200
0.01% 330
2019
Q3
$203K Hold
1,200
0.01% 389
2019
Q2
$220K Hold
1,200
0.01% 378
2019
Q1
$221K Buy
+1,200
New +$221K 0.01% 375
2018
Q4
Sell
-1,200
Closed -$231K 429
2018
Q3
$231K Hold
1,200
0.01% 385
2018
Q2
$204K Buy
+1,200
New +$204K 0.01% 366
2017
Q4
Sell
-3,270
Closed -$497K 408
2017
Q3
$497K Hold
3,270
0.03% 242
2017
Q2
$421K Buy
3,270
+800
+32% +$103K 0.02% 245
2017
Q1
$270K Buy
+2,470
New +$270K 0.01% 316